Oxford University Innovation’s Clinical Outcomes manages the provision (licensing) and support of high quality clinical outcome assessment (COA) measures developed at the University of Oxford and elsewhere. The vast majority of our measures are Patient Reported Outcome (PRO) Measures (or sometimes referred to as PROMs).
We provide licences for some of the most respected and widely deployed outcome measures used by the pharmaceutical industry, healthcare providers, academia and medical device manufacturers.
The Clinical Outcomes team can also provide expert consultancy advice on the development and psychometric validation of new COAs and PROs, as well as the use of our own and other health outcome measures.
With over 10 million people currently living with arthritis, Versus Arthritis (formerly Arthritis Research UK) pushes to defy the disease!
Oxford University Innovation's Clinical Outcome team will be attending the ISOQOL annual conference in Dublin, Ireland from the 24th - 27th October 2018.
Health Outcomes Insights helps healthcare agencies and pharmaceutical companies across a range of conditions including diabetes, get targeted answers to patient behaviour.
